1. Home
  2. AEHR vs DRUG Comparison

AEHR vs DRUG Comparison

Compare AEHR & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aehr Test Systems

AEHR

Aehr Test Systems

HOLD

Current Price

$90.21

Market Cap

858.8M

Sector

Industrials

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$84.59

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHR
DRUG
Founded
1977
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.8M
707.1M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
AEHR
DRUG
Price
$90.21
$84.59
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$29.50
$129.25
AVG Volume (30 Days)
4.2M
160.2K
Earning Date
04-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,968,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$71.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.06
$23.18
52 Week High
$102.48
$123.75

Technical Indicators

Market Signals
Indicator
AEHR
DRUG
Relative Strength Index (RSI) 64.20 51.41
Support Level $21.95 $72.06
Resistance Level $102.48 $91.69
Average True Range (ATR) 9.37 4.22
MACD -1.31 -0.77
Stochastic Oscillator 53.55 37.93

Price Performance

Historical Comparison
AEHR
DRUG

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: